INVO Bioscience, Inc.·4

May 22, 8:01 PM ET

Goren Andrea 4

4 · INVO Bioscience, Inc. · Filed May 22, 2023

Insider Transaction Report

Form 4
Period: 2023-05-18
Goren Andrea
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2023-05-18+81,00081,000 total
    Exercise: $0.37Exp: 2033-05-17Common Stock (81,000 underlying)
Footnotes (1)
  • [F1]The option vests in twelve equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

Documents

1 file
  • 4
    ownership.xmlPrimary